Japan Drug Makers Look To Anti-Flu, Other Vaccines For Future Sales
This article was originally published in PharmAsia News
Executive Summary
Japanese drug makers, prompted partly by influenza outbreaks and in part by patent expirations, are focusing increasingly on vaccines for future sales